Submission Details
| 510(k) Number | K242685 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 06, 2024 |
| Decision Date | December 04, 2024 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K242685 is an FDA 510(k) clearance for the Atellica? CH Creatinine_3 (Crea3), a Alkaline Picrate, Colorimetry, Creatinine (Class II — Special Controls, product code CGX), submitted by Siemens Healthcare Diagnostics, Inc. (New York, US). The FDA issued a Cleared decision on December 4, 2024, 89 days after receiving the submission on September 6, 2024. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1225.
| 510(k) Number | K242685 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 06, 2024 |
| Decision Date | December 04, 2024 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CGX — Alkaline Picrate, Colorimetry, Creatinine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1225 |